FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to nephrology. The patient performs venipuncture to collect blood in a test tube of two milliliters. After that, the tube is left standing for 15-30 minutes at room temperature in a vertical position, then the tube is centrifuged for 15 minutes at 2500 rpm. Next, the blood serum is taken from the test tube to the supernatant gel, and then the concentration of IL-6 is determined by the method for semi-open enzyme immunoassay. Further, the formula determines the coefficient (C) of the probability of the presence of PEM. At the obtained values of C ≤ 0.92, the absence of PEM is stated, at C 0.93-1.71, the mild stage of PEM is determined, and at C ≥ 1.72, the moderate stage of PEM is determined.
EFFECT: The method is promising, simple, accessible and informative, allows you to timely detect the presence of PEM and optimize approaches to the pharmacological correction of this clinical condition.
1 cl, 1 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIAGNOSING SARCOPENIA IN PATIENTS WITH STAGE 5 CHRONIC KIDNEY DISEASE RECEIVING TREATMENT WITH LONG-TERM HEMODIALYSIS | 2020 |
|
RU2756154C1 |
METHOD OF TREATING CHRONIC KIDNEY DISEASE IN PREDIALYTIC AND DIALYTIC PERIODS AND MEDICATION FOR ITS REALISATION | 2009 |
|
RU2400251C1 |
METHOD FOR PREDICTING SARCOPENIA IN PATIENTS RECEIVING CHRONIC HEMODIALYSIS TREATMENT | 2023 |
|
RU2811653C1 |
METHOD FOR ASSESSING PRONOUNCED FIBROPLASTIC CHANGES IN TUBULOINTERSTITIUM OF RENAL PARENCHYMA IN PATIENTS WITH KIDNEY DAMAGE ASSOCIATED WITH MONOCLONAL GAMMOPATHY | 2021 |
|
RU2757588C1 |
METHOD FOR ASSESSING INTESTINAL EPITHELIAL BARRIER PERMEABILITY IN PATIENTS RECEIVING HEMODIALYSIS TREATMENT | 2023 |
|
RU2817667C1 |
METHOD FOR PREDICTION OF DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN INDIVIDUALS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2020 |
|
RU2774598C2 |
NON-INVASIVE DIAGNOSTIC TECHNIQUE FOR TUBULOINTERSTITIAL FIBROSIS ACCOMPANYING FOCAL SEGMENTAL GROMELUROSCLEROSIS | 2014 |
|
RU2575826C2 |
METHOD OF ASSESSING EFFECTIVENESS OF NEPHROPROTECTIVE THERAPY IN HYPERTENSIVE PATIENTS WITH STAGE C2 CHRONIC KIDNEY DISEASE | 2023 |
|
RU2810453C1 |
METHOD FOR ASSESSING RISK OF DEVELOPING CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH DIABETIC NEPHROPATHY AT ALL STAGES OF CHRONIC KIDNEY DISEASE | 2023 |
|
RU2823471C1 |
METHOD FOR EARLY DIAGNOSIS OF ENDOTHELIAL RENAL DYSFUNCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2020 |
|
RU2767701C1 |
Authors
Dates
2022-04-18—Published
2021-08-24—Filed